Protective role of Helicobacter pylori against inflammatory bowel disease: A hypothesis

Practical Gastroenterology

Volumn 33, Issue 9, 2009, Pages

  Sonnenberg, Amnon ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROHN DISEASE; ENTERITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; REVIEW; ULCERATIVE COLITIS;

EID: 76149099579     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Marugame T, Dongmei Q. Comparison of time trends in stomach cancer incidence (1973 1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vol. IV-VIII. Jpn J Clin Oncol, 2007;37:242 243.
2. Mendeloff AI. What has been happening to duodenal ulcer? Gastroenterology, 1974;67: 1020-1022.
3. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut, 1998;43:327-333.
4. Sonnenberg A. The US temporal and geographic variations of diseases related to Helicobacter pylori. Am J Public Health, 1993;83:1006-1010.
5. Delcò F, Sonnenberg A. Birth-cohort phenomenon in the time trends of mortality from ulcerative colitis. Am J Epidemiol, 1999;150:35-366.
6. Sonnenberg A, Chang J. Time trends of physician visits for Crohn's disease and ulcerative colitis in the United States 1960-2006. Inflam Bowel Dis, 2008;14:249 252.
7. Sonnenberg A. Hospitalization for inflammatory bowel disease in the United States between 1970 and 2004. J Clin Gastroenterol, 2009:43:297-300.
8. Sonnenberg A. Temporal changes in the age distribution of IBD hospitalization Data from England and Scotland. Eur J Gastroenterol Hepatol, 2009;21: in press.
9. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther, 1995; 9 (Suppl 2): 45 51.
10. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis, 1993;168:219-221.
11. Bergenzaun P, Kristinsson KG, Thjodleifsson B, Sigvaldadottir E, Mölstad S, Held M, Wadström T. Seroprevalence of Helicobacter pylori in south Sweden and Iceland. Scand J Gastroenterol, 1996;31:1157-1161.
12. Collett JA, Burt MJ, Frampton CM, Yeo KH, Chapman TM, Buttimore RC, Cook HB, Chapman BA. Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies. NZ Med J, 1999;112:292-295.
13. Naja F, Kreiger N, Sullivan T. Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol, 2007;21:501-506.
14. Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease antibiotic use in the history does not play a significant role. Helicobacter, 2004;9:278-283.
15. Vare PO, Heikius B, Silvennoinen JA, Karttunen R, Niemela SE, Lehtola JK, Karttunen TJ. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol, 2001;36:1295-1300.
16. Halme L, Rautelin H, Leidenius M, Kosunen TU. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol, 1996;49:65-67.
17. Sonnenberg A, Koch TR. Period and generation effects on mortality from idiopathic inflammatory bowel disease. Dig Dis Sci, 1989;34:1720-1729.
18. Sonnenberg A. Time trends of mortality from Crohn's disease and ulcerative colitis. Int J Epidemiol, 2007:36:890-899.
19. Sandler RS, Golden AL. Epidemiology of Crohn's Disease. J Clin Gastroenterol, 1986;8: 160-165.